The Section 232 determination on robotics is overdue. Run the automation math at every plausible tariff rate and the answer barely moves.
On September 2, 2025, the Commerce Department opened a Section 232 national security investigation into imports of robotics and industrial machinery. The scope was drawn broadly: CNC machining centers, turning and milling machines, grinding and deburring equipment, industrial stamping and pressing machines, and the programmable computer-controlled systems that integrate them. The statute allowed Commerce until May 30, 2026 to transmit its report to the President.
That deadline came and went. The report is overdue. The investigation remains open.
For ten months, capital committees across American manufacturing have used this as a reason to wait. It is a defensible reason. Nobody wants to sign a $2 million purchase order on imported equipment weeks before a 50 percent duty lands on it. The prudent move, obviously, is to wait for clarity.
Except almost nobody who is waiting has done the arithmetic on what clarity would actually change.
If the answer is the same at zero percent, 25 percent, and 50 percent, then you are not waiting for information. You are waiting for permission.
Take a representative automation decision. A shop is evaluating a robotic machining cell at roughly $2.4 million landed. The justification is labor: they cannot staff a second shift, they have been turning away work, and the cell would let them run largely unattended overnight. Call the incremental contribution $180,000 a month once the cell is proven, with a ramp period before that. Payback lands somewhere in the eighteen-to-twenty-four month range, which is typical for this class of project in the current labor market.
That last point is the one the waiting analysis consistently omits. Deferral is treated as a neutral position, as though the manufacturer simply holds still until better information arrives. It is not neutral. It has a running cost, and in this case the running cost is the contribution margin from work that is being declined every month the capacity does not exist.
Ten months of that is not a rounding error. For the shop in the example, ten months of deferral consumed more value than a 50 percent tariff would have. The manufacturer who waited to avoid a hypothetical cost has, with certainty, incurred a larger real one.
It gets worse, because the waiting did not preserve the original terms. Machine tool order values have climbed sharply — nearly 32 percent year over year through May — with the industry now openly monitoring its own capacity constraints and warning about expanding delivery times as order books fill. IMTS falls in the second half and reliably pulls orders forward. The manufacturer who deferred in February to avoid tariff risk now faces a quotation where the machine costs more, the lead time is longer, and the tariff question is still open.
They did not avoid the risk. They converted a pricing risk into a schedule risk — and paid a premium for the conversion.
None of this argues that tariff exposure is irrelevant. It argues that tariff exposure is a variable to be structured around rather than a reason to stop. And the structuring options are genuinely useful when the capital partner is thinking about them: sourcing domestic content where the capability exists, sequencing procurement so that import-exposed components land inside a defined window, building duty contingency into the project budget rather than the decision, or financing the project in a way that absorbs a cost variance without reopening the credit approval.
That last one deserves attention, because it is where a lot of deferral actually originates. A manufacturer with an approved facility sized to a specific project cost knows that a 25 percent cost increase means going back to the credit committee. Going back to the committee means weeks, and possibly a different answer. So the safer move is to wait until the number is certain — not because the economics demand it, but because the financing structure cannot accommodate a moving one.
That is a capital structure problem being experienced as a policy problem. The manufacturers who have kept moving through this period generally have capital arrangements with enough headroom and enough flexibility that a cost variance is a conversation rather than a reapproval.
The determination will land. It could be next month or in the fourth quarter, and it may or may not be capped by the trade framework arrangements that limit certain partners. When it does, the manufacturers who spent ten months waiting will discover two things simultaneously: what the number is, and that everyone else who was waiting is now trying to execute in the same quarter, against the same builders, integrators, and capital providers.
Clarity, when it finally arrives, is going to be extremely crowded.
First National Capital Corporation structures equipment and project capital with the flexibility to absorb cost variance without restarting credit approval — $500K to $250M+, no covenants, closings measured in weeks. Start a conversation.